WHO ICTRP trial
The Efficacy of Hepatitis B Virus (HBV) Vaccination in Patients with Previously…
JPRN-UMIN000042288 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000042288 |
|---|---|
| Public title | The Efficacy of Hepatitis B Virus (HBV) Vaccination in Patients with Previously Resolved HBV Infection Receiving Immunosuppressive Therapy to Prevent HBV Reactivation through Increase of Serum Levels of Anti-HBs (Pilot Study) |
| Scientific title | The Efficacy of Hepatitis B Virus (HBV) Vaccination in Patients with Previously Resolved HBV Infection Receiving Immunosuppressive Therapy to Prevent HBV Reactivation through Increase of Serum Levels of Anti-HBs (Pilot Study) - Hepatitis B Virus Vaccination to Prevent HBV Reactivation |
| Primary sponsor | Saitama Medical University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Collagen disease, collagen disease related disease, ulcerative colitis, Crohn's disease, intestinal Behcet's disease (simple ulcers included), psoriasis, and diseases that require other immunosuppressive therapies. |
| Interventions | HBV vaccines at a volume of 0.5 mL are administrated by intramuscular injection for 3 times at baseline and 4 and 20 weeks later. If anti-HBs titer is less than 10 mIU /mL after vaccinations, HBV vaccines are administrated for 3 times… |
| Registration date | Oct 30, 2020 |
| Target size | 20 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: